News

Earnings live: Palantir stock pops, Pfizer beats, Caterpillar warns of tariff impact

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

These Analysts Increase Their Forecasts On Regeneron Pharmaceuticals After Better-Than-Expected Earnings

RBC Capital analyst Brian Abrahams maintained the stock with a Sector Perform and raised the price target from $688 to $695.

Earnings live: Palantir stock pops on raised outlook, Hims & Hers tumbles

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...